Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst’ protocol
Open Access
- 3 October 2024
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-11
Abstract
Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms. This objective will be assessed using the Acute Cystitis Symptom Score. PharmaCyst’ is an open-label, multicenter, controlled, cluster-randomized study conducted in the Loire region, France. Women aged between 18 and 65 years presenting to a pharmacy complaining of at least one symptom of an uncomplicated urinary tract infection present over the last 3 days (including burning pain during micturition, dysuria, pollakiuria, urgent urination) will be considered for inclusion. All patients will be contacted on day 3, 10, and month 3. A total of 480 patients need to be recruited for the 24 clusters participating in the research. The quantitative data will be described using means and standard deviations and compared using Student’s t-test. The qualitative data will be described using numbers and percentages and compared using chi2 test (or Fisher’s exact test if necessary). The primary and secondary outcomes analyses will consider the intention-to-treat population. PharmaCyst’ is the first clinical trial conducted in France only by community pharmacists. Its results could lead to an extension of the protocol. The protocol has been approved by the French ethics committee on 2022/12/02 and is registered under the number 49RC22_0240 on ClinicalTrials.gov.Keywords
This publication has 20 references indexed in Scilit:
- Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III TrialUrologia Internationalis, 2018
- Building capacity in primary care: the implementation of a novel ‘Pharmacy First’ scheme for the management of UTI, impetigo and COPD exacerbationPrimary Health Care Research & Development, 2018
- Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort studyBMC Infectious Diseases, 2016
- The Acute Cystitis Symptom Score for Patient-Reported Outcome AssessmentUrologia Internationalis, 2016
- Evaluating pharmacist prescribing for minor ailmentsInternational Journal of Pharmacy Practice, 2014
- Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional studyBritish Journal of General Practice, 2013
- Pharmacist prescribing in primary care: the views of patients across Great Britain who had experienced the serviceInternational Journal of Pharmacy Practice, 2011
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Patterns of intra-cluster correlation from primary care research to inform study design and analysisJournal of Clinical Epidemiology, 2004
- Urinary Tract InfectionAnnals of Epidemiology, 2000